top of page

Introduction

Autism is a neurodevelopmental disorder affecting speech, behavior, and socialization. It is a lifelong condition with no cure. The mainstay of current treatment for Autism is 1-on-1 behavioral, speech, and occupational therapy. There are no FDA approved drugs to specifically treat Autism, although several drugs are used with limited benefit.

Sirica Therapeutics is developing a digital therapeutic system that integrates virtual reality, video gaming, advanced robotics, and physical exercise in a deeply immersive environment. It is an early-stage startup seeking pre-seed funding.

Autism is the fastest growing developmental disorder, increasing at 8% per year.

Market Opportunity

In the US alone, the lifetime cost of autism over the last 30 years is estimated at $7 trillion and expected to reach $15 trillion over the next decade. 

In the US alone, the lifetime cost of autism over the last 30 years is estimated at $7 trillion and expected to reach $15 trillion over the next decade. 

Our Solution 

Sirica Therapeutics has built a digital therapeutic system that integrates virtual reality, video gaming, advanced robotics, and physical exercise in a deeply immersive environment.

Our Cognitive Sensorimotor Therapy ™  is a scalable, engaging, intelligent, and cost-efficient solution. We have successfully established Safety and Feasibility in our first clinical study involving 9 individuals with Autism. Our next milestone is to conduct a larger Efficacy study.

We are raising a pre-seed round and are inviting the Autism community to participate. We welcome you to join us as we accelerate our journey to bring this solution to the many individuals and families who desperately need it. 

 

We’re offering a future opportunity to invest $250 or more in Sirica Therpautics and make a difference in the lives of people affected by Autism.

Investor Interest 

I am interested in investing $250 or more in Sirica Therapeutics. 

Thanks for submitting!

NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED, AND IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL THE OFFERING STATEMENT IS FILED AND ONLY THROUGH AN INTERMEDIARY’S PLATFORM. AN INDICATION OF INTEREST INVOLVES NO OBLIGATION OR COMMITMENT OF ANY KIND. "RESERVING" SECURITIES IS SIMPLY AN INDICATION OF INTEREST.

What describes you best. Check all that apply.

Sirica Therapeutics has built a digital therapeutic system that integrates virtual reality, video gaming, advanced robotics, and physical exercise in a deeply immersive environment.

 

Our Cognitive Sensorimotor Therapy ™  is a scalable, engaging, intelligent, and cost-efficient solution. We have successfully established Safety and Feasibility in our first clinical study involving 9 individuals with Autism. Our next milestone is to conduct a larger Efficacy study.

Our Solution 

We are raising a pre-seed round and are inviting the Autism community to participate. We welcome you to join us as we accelerate our journey to bring this solution to the many individuals and families who desperately need it.

We’re offering a future opportunity to invest $250 or more in Sirica Therpautics and make a difference in the lives of people affected by Autism. 
 

bottom of page